* [ESETT](https://www.nejm.org/doi/full/10.1056/NEJMoa1905795) (2019)
	* Americans >2 years old with convulsive status epilepticus unresponsive to benzodiazepines, without another precipitant of seizure
	* Investigator-initiated, blinded, adaptive trial
	* Comparison of levetiracetam, fosphenytoin, and valproate
	* Absence of clinically apparent seizures and improving responsiveness after 60 minutes from trial drug delivery
	* Stopped early for futility, with no significant difference in ICU admission or safety outcomes)
	* Demonstrates the superiority of levetiracetam, as it avoids the complexities of dosing and monitoring valproate and fosphenytoin